Home
Media

CALIXAR Best Inventing French-Tech Company 2018

May 16, 2018

Lyon (France), May 16, 2018 – CALIXAR, the French biotech company specialized in the native isolation of complex therapeutic targets and antigens, is proud to announce its nomination by Patent-Angels.com in Forbes as Best Inventor 2018 of the French Auvergne-Rhône Region among French-Tech start-up companies. At the national level CALIXAR reaches the 38th place out of the Top 100.

This ranking takes into account the total number of different patented inventions hold by each company. With a strong portfolio of 7 patent families, and despite a strong competition, CALIXAR has been able to take the first place of its region.

More information here (article in French).

Read the article
Share this post
Conformational antibody development
Vaccine development
Ligand high-throughput screening
Structure-based drug discovery
Immunoassays
Deorphanization projects
Identification of relevant targets
Expression of full-length membrane proteins
Functional isolation and stabilization of targets
Conformational antibody development
Vaccine development
High-throughput ligand screening
Structure-based drug discovery
Immunoassays
Deorphanization projects
Identification of relevant targets
Expression of full-length membrane proteins
Functional isolation and stabilization of targets

Secure and boost
your discovery programs.

Starting from native material or recombinant systems, we succeed with all types of membrane proteins: GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.

Contact us
Our partners